A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).

NCT00044226 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
350
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Milkhaus Laboratory